On September 7, 2021 Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, reported that Shawn M. Leland, PharmD, Rph, Founder and Chief Executive Officer of Elevation Oncology, will present virtually at the H.C. Wainwright 23rd Annual Global Investment Conference (Press release, Elevation Oncology, SEP 7, 2021, https://www.prnewswire.com/news-releases/elevation-oncology-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference-301369354.html [SID1234587353]). The presentation will be available on demand starting at 7:00 a.m. ET on Monday, September 13, 2021.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A webcast of the event will be accessible for 30 days on the Events page of the Company’s Investor Relations website at View Source